Google DeepMind won bragging rights that its competitors in the field of AI could only dream of. A share of the 2024 Nobel Prize in Chemistry was awarded to Demis Hassabis, its CEO, and John Jumper, ...

The AI revolution is driving tension between new technology and the traditional approaches in drugmaking. Biopharma leaders ...

As earlier published that Demis Hassabis, the CEO of Google DeepMind won the Nobel Prize, but interestingly, he did not win ...

Drug discovery has traditionally been slow, expensive and prone to failure, but AI and machine learning are set to change all ...

Researchers used an AI model to create a new image of the black hole at the center of the Milky Way, with some concern from ...

The number of scientific papers that rely on AI has quadrupled, and the scope of problems AI can tackle is expanding by the ...

More than 30 Nobel Laureates and 620 Young Scientists representing 85 nationalities in Lindau • Programme dedicated to the Nobel Prize discipline of Chemistry • To be debated at the Opening Ceremony: ...

AI’s advantage over humans comes down to 4 dimensions: speed, scale, scope and sophistication. Whether AI can replace you ...

In the 2010s, the DeepMind co-founder used AlphaFold to precisely describe the three-dimensional protein structure, solving a 50-year-old problem and winning the Nobel Prize in Chemistry in 2024.

Google's DeepMind launches AlphaGenome, an artificial intelligence model that predicts gene expression from DNA sequence.

The stunning advance of AlphaFold2, the AI model of structural biology whose creators Demis Hassabis and John Jumper were ...

Google DeepMind has launched a new AI model called AlphaGenome. The new tool will aim to predict how genetic mutations impact ...